Nix ๐ retweeted
๐ฅ Please watch this entire video before commenting. โผ๏ธ
If you've been sitting on the fence, or you follow me just for the laughs because you don't share the same perspective I do, please listen. โผ๏ธโผ๏ธ
โAre you willing to question what you've always believed?โ๏ธโ๏ธโ๏ธ
Your journey toward understanding begins with you. โผ๏ธ
I'm here to share my perspective and encourage you to explore ideas for yourself. I also encourage you to do your own research and think critically about the information you encounter. My own journey of questioning and learning began in 1993, when I was 14 years old.
Many of us grow up accepting ideas without ever examining them.
If this message resonates with you, share it and encourage others to think, ask questions, and seek understanding for themselves.
๐ฅ๐ฅ๐ฅ๐ธโค๏ธ๐ค๐๐ธ
Nix ๐ retweeted
Give me Sammy Halen any day! Not saying its better, but its just as good! Rock N Roll!
Nix ๐ retweeted
$NWBO #DCVax @DrOzCMS @SecKennedy @Siobhain_Mc @MHRAgovuk
Do the right thing and get this life-saving treatment approved now! GBM patients cannot wait!!
Replying to @jstrattman @Siobhain_Mc
I got the DCVax in 2015 @UCLAStrokeNSG by one of its creators Dr. Linda Liau after the grim diagnosis of a Glioblastoma Multiforme. Iโve thrived for over 11 & a half years. NO TUMOR RECURRENCE!!! How many times do I have to tell my story, it feels like Iโm screaming into an echo chamber. F.F.S it works.
@LisainNJUSA @kshaughnessy2 @DCVaxDefender @HollensbeAmanda @peter_brit @TheLastWord @LastWeekTonight
Nix ๐ retweeted
#SITC26 #SITC2026 #DCVaxForBraelyn
$NWBO $MRK $MRNA $BNTX $RHHBY
#DCVax #DendriticCells #CancerVaccines #ุณุจูู
ุงูู
๐ง๐ต๐ฒ ๐ฐ๐ฒ๐น๐น ๐บ๐ถ๐๐๐ถ๐ป๐ด ๐ณ๐ฟ๐ผ๐บ ๐ก๐ฎ๐๐๐ฟ๐ฒโ๐ ๐ป๐ฒ๐ ๐ฐ๐ฎ๐ป๐ฐ๐ฒ๐ฟ-๐๐ฎ๐ฐ๐ฐ๐ถ๐ป๐ฒ ๐ฎ๐ฟ๐๐ถ๐ฐ๐น๐ฒ ๐ถ๐ ๐๐ต๐ฒ ๐ผ๐ป๐ฒ ๐ฅ๐ฎ๐น๐ฝ๐ต ๐ฆ๐๐ฒ๐ถ๐ป๐บ๐ฎ๐ป ๐ฑ๐ถ๐๐ฐ๐ผ๐๐ฒ๐ฟ๐ฒ๐ฑ.
Asher Mullardโs Nature Reviews Drug Discovery article, โCancer vaccine development gets complicated,โ asks which targets, patients and combinations will deliver lasting benefit. It never names the dendritic cell.
Yet one of its leading experts, Ira Mellman, was Ralph Steinmanโs longtime collaborator. Together, they helped explain how dendritic cells process material, present selected targets and shape the instructions T cells receive.
๐ง๐ต๐ฒ ๐ฎ๐ฟ๐๐ถ๐ฐ๐น๐ฒโ๐ ๐ผ๐๐ป ๐ฒ๐
๐ฝ๐ฒ๐ฟ๐๐ ๐น๐ฒ๐ฎ๐ฑ ๐ฏ๐ฎ๐ฐ๐ธ ๐๐ผ ๐๐ต๐ฒ ๐บ๐ถ๐๐๐ถ๐ป๐ด ๐ฐ๐ฒ๐น๐น.
Personalized RNA vaccines use software to select candidate tumor targets.
๐๐ฒ๐ป๐ฑ๐ฟ๐ถ๐๐ถ๐ฐ ๐ฐ๐ฒ๐น๐น๐ ๐ฑ๐ผ ๐ฏ๐ถ๐ผ๐ถ๐ป๐ณ๐ผ๐ฟ๐บ๐ฎ๐๐ถ๐ฐ๐ ๐ณ๐ผ๐ฟ ๐ฎ ๐น๐ถ๐๐ถ๐ป๐ด.
They process tumor material, present selected pieces to T cells and supply signals that help direct an attack while maintaining restraint toward healthy tissue.
RNA vaccines work through presenting cells already in the patient. DCVax, from Northwest Biotherapeutics, makes preparing those cells part of the medicine.
DCVax-L brings tumor material to the cells: the patientโs dendritic cells are loaded in the laboratory.
DCVax-Direct brings the cells to the tumor: partly activated, unloaded cells are injected to collect material there.
๐ฃ๐ฟ๐ฒ๐ฝ๐ฎ๐ฟ๐ฒ๐ฑ ๐ผ๐๐๐๐ถ๐ฑ๐ฒ ๐๐ต๐ฒ ๐ฏ๐ผ๐ฑ๐. ๐ช๐ผ๐ฟ๐ธ๐ถ๐ป๐ด ๐ถ๐ป๐๐ถ๐ฑ๐ฒ ๐ถ๐.
Preparation shapes the instructor. After the cells return, helper T cells and dendritic cells reinforce each other through reciprocal licensing. Killer T cells attack. Dying cancer cells release fresh material for another round of presentation.
In the pancreatic RNA-vaccine follow-up, one patientโs vaccine-trained T cells lasted for years. When the cancer returned in the lung, those cells were inside the new tumor.
When the cancer changes, the lesson has to change with it. Durable control depends on that cooperation continuing.
The instructorโs function can be improved in the laboratory. In Northwestโs work presented at the New York Academy of Sciences, selected preparation conditions turned low-producing cells into high producers of certain immune signals.
Three decades of dendritic-cell vaccine research belong at the center of this debate.
๐ง๐ต๐ฒ ๐๐ฎ๐ฟ๐ด๐ฒ๐ ๐ฏ๐ฒ๐ด๐ถ๐ป๐ ๐๐ต๐ฒ ๐น๐ฒ๐๐๐ผ๐ป. ๐ง๐ต๐ฒ ๐ถ๐ป๐๐๐ฟ๐๐ฐ๐๐ผ๐ฟ ๐ฏ๐ฒ๐น๐ผ๐ป๐ด๐ ๐ถ๐ป ๐๐ต๐ฒ ๐บ๐ฒ๐ฑ๐ถ๐ฐ๐ถ๐ป๐ฒ.
๐ Full X Article
nitter.gq/andrewcaravello/articlโฆ
๐ LinkedIn Article
linkedin.com/pulse/missing-cโฆ
๐ธ๐ฆ ุจุงูุนุฑุจูุฉ ุนูู ููุงู
ูุฑ
ุงูุฎูุงูุง ุงูู
ุชุบุตูุฉ ูุงูุชุนุงูู ุงูุณุนูุฏู ุงูุจุฑูุทุงูู ูุงูุชุญูู ูู ุฑุนุงูุฉ ุงูุณุฑุทุงู.
hawamer.com/vb/hawamer301785โฆ
@aljedai
Cancer vaccine development gets complicated
nature.com/articles/d41573-0โฆ
Merck and Modernaโs intismeran autogene succeeded in a landmark melanoma trial, but the oncology community still has more questions than answers about the future of cancer vaccines.
Nix ๐ retweeted
Replying to @MHRAgovuk
@MHRAgovuk @FDA @FDADrugs @SecKennedy @DrOzCMS @POTUS @VP @greta @mcuban @cvpayne Approve $NWBO โs #DCVax now! It cures glioblastoma now!!!
$NWBO
@NorthwestBioโs DCVax platform saved Brad Silverโs life.
More than 20 years ago he was diagnosed with glioblastoma and given 2 months to live.
Then he met Dr Linda Liau and Dr. Robert M. Prins at @UCLAStrokeNSG and was accepted into a clinical trial for DCVax.
DCVax is a non-toxic promising Phase 3 treatment for glioblastoma and all solid tumors.
Thanks @peter_brit for the find.
Nix ๐ retweeted
#DCVax is a #paradigmshift in #cancer from $NWBO for all #solid tumor. It is #autologous meaning ...
#moral - no questionably sourced cells
#safe - no deadly side-effects
#effective - customized just for you
#REPEATABLE - do it again overcoming resistance from mutations
Nix ๐ retweeted
$NWBO
It is time to take a swift action to make the best cancer treatment available for all patients who have terminal cancer.
accessconsortium.info/homepaโฆ
#dcvax $nwbo #gbm
MHRA - A significant step forward for international Regulatory Collaboration..
linkedin.com/posts/medicinesโฆ
investorshub.advfn.com/boardโฆ
Nix ๐ retweeted
I traveled to Mt. Orab, Ohio, today for a 'machine' part. What I found 'broke' my heart. ๐
Nix ๐ retweeted
Public Service Announcement for @SpeakerJohnson and @JDVance :
Speaker Mike Johnson Now-Jan 3, order CPB Chair to conduct CI Investigation on all members and staff and release all CCTV, docs, comms of USCP GC
Senate President JD Vance direct vote on all outstanding bills and confirmations, CI Investigation via SSAA
Dec 18, 2026 EO 13848, Deliver a message to Senate on the foreign interference in Senate election, Mike Johnson has until January 3 to deny seating those members who โwonโ due to foreign interference in this ICA
JD Vance Jan 3, 2027-Jan 3, 2028 Senate Sergeant at Arms conduct what Mike Johnson fails to do before Jan 3
Jan 2028 Iowa Caucuses goers will judge JD based on his performance above, details in video:
Nye Bevan built the NHS by bulldozing bureaucracy to save British lives while Clement Attlee warned that "government by discussion is only effective if you can stop people talking."
โ@MHRAgovuk @10DowningStreet @andyburnham approve $NWBO DCVax for ๐ฌ๐ง victory over scarcity.
Nix ๐ retweeted
Replying to @kshaughnessy2 @Siobhain_Mc
The fact that others, less proven, less safe and less effective get approval while DCVax sits in review for 1,064 days and counting is just disturbing on so many levels! @MHRAgovuk itโs time!! People are dying needlessly and only you can stop it! Approve #DCVax now!!
Nix ๐ retweeted
Replying to @Siobhain_Mc
There are impressive phase 3 trial results for DCVax which is a non-toxic treatment for glioblastoma and all solid tumors - it needs approval.
Why do treatments that are not nearly as proven get approved more quickly?
Nix ๐ retweeted
Replying to @Siobhain_Mc
$NWBO #DCVax #DCVaxForBraelyn #Glioblastoma
Siobhain, please put Braelyn Hollensbe and DCVax-L at the centre of this debate. Sharon Hodgson raised Braelynโs case in the Commons on 4 November.
๐ฃ๐ต๐ฎ๐๐ฒ ๐๐๐ ๐ถ๐ ๐ฐ๐ผ๐บ๐ฝ๐น๐ฒ๐๐ฒ. ๐ง๐ต๐ฒ ๐ฟ๐ฒ๐๐๐น๐๐ ๐ฎ๐ฟ๐ฒ ๐ฝ๐๐ฏ๐น๐ถ๐๐ต๐ฒ๐ฑ.
DCVax-L has completed a 331-patient phase III trial. Its published survival analysis reported five-year survival of 13.0% versus 5.7% in external controls.
Subsequent patient-level propensity-score matching, presented at BNOS, reported median survival advantages of 3.4โ6.3 months. A separate weighting method produced directionally consistent findings.
INSIGhT independently tested the external-control approach against known randomized results. Carefully matched external controls reproduced the absence of survival benefit for three experimental drugs. That gives the method a concrete benchmark in glioblastoma.
๐ก๐๐ฆ ๐๐น๐ผ๐ผ๐ฑ ๐ฎ๐ป๐ฑ ๐ง๐ฟ๐ฎ๐ป๐๐ฝ๐น๐ฎ๐ป๐ ๐ถ๐ ๐ฎ๐น๐ฟ๐ฒ๐ฎ๐ฑ๐ ๐๐๐ฝ๐ฝ๐ผ๐ฟ๐๐ถ๐ป๐ด ๐ฝ๐ฟ๐ผ๐ฑ๐๐ฐ๐๐ถ๐ผ๐ป.
On 8 October, NHS Blood and Transplant announced a collaboration with Northwest Biotherapeutics and Advent BioServices to support DCVax-L production, initially involving Leeds and Oxford.
This is a patient-derived treatment: the patientโs own dendritic cells are loaded with material from that patientโs tumor. The phase III publication described treatment as well tolerated.
CheckMate 143, 498 and 548 failed to improve survival in glioblastoma. Ipi-Glio failed too. WIN-Glio is a separate phase I study testing ipilimumab before standard treatment. Its recruitment, safety and survival reporting should be transparent.
๐๐ผ๐บ๐ฏ๐ถ๐ป๐ฎ๐๐ถ๐ผ๐ป ๐ฑ๐ฒ๐๐ฒ๐น๐ผ๐ฝ๐บ๐ฒ๐ป๐ ๐บ๐๐๐ ๐ฎ๐ฑ๐ฑ๐ฟ๐ฒ๐๐ ๐ถ๐บ๐บ๐๐ป๐ฒ ๐ถ๐ป๐๐๐ฟ๐๐ฐ๐๐ถ๐ผ๐ป.
Put DCVax-L at the foundation of that work: prepare the cells that teach the immune response, then test the partners that sustain its attack. Dendritic-cell vaccination and checkpoint blockade address complementary parts of the task.
The UK marketing application was submitted in December 2023. Northwestโs November 2026 filing still describes the MHRA review as ongoing.
What specific issues remain unresolved? Who is responsible for resolving them, and on what timetable? What patient-access arrangements are being prepared alongside the review?
๐ฃ๐ฎ๐๐ถ๐ฒ๐ป๐๐ ๐ฐ๐ฎ๐ป๐ป๐ผ๐ ๐๐ฝ๐ฒ๐ป๐ฑ ๐๐ต๐ฒ ๐ฟ๐ฒ๐๐ ๐ผ๐ณ ๐๐ต๐ฒ๐ถ๐ฟ ๐น๐ถ๐๐ฒ๐ ๐๐ฎ๐ถ๐๐ถ๐ป๐ด ๐ณ๐ผ๐ฟ ๐ฎ๐ป๐๐๐ฒ๐ฟ๐.
EVIDENCE
DCVax-L phase III results and safety:
jamanetwork.com/journals/jamโฆ
BNOS propensity-score matching and weighting analyses:
nwbio.com/wp-content/uploadsโฆ
INSIGhT external-control reanalysis:
pubmed.ncbi.nlm.nih.gov/4217โฆ
NHSBT production collaboration:
nwbio.com/northwest-biotheraโฆ
Current company filing on the MHRA review:
sec.gov/Archives/edgar/data/โฆ
CheckMate 143:
pmc.ncbi.nlm.nih.gov/articleโฆ
CheckMate 498:
pmc.ncbi.nlm.nih.gov/articleโฆ
CheckMate 548:
pmc.ncbi.nlm.nih.gov/articleโฆ
Ipi-Glio:
pubmed.ncbi.nlm.nih.gov/4080โฆ
WIN-Glio registration:
clinicaltrials.gov/study/NCTโฆ
UCLA combination research using its academic ATL-DC vaccine, Hiltonol and pembrolizumab:
clinicaltrials.gov/study/NCTโฆ
Braelynโs case raised in Parliament:
hansard.parliament.uk/pdf/coโฆ
Nix ๐ retweeted
Replying to @Siobhain_Mc
You are absolutely right, MP McDonagh. Brain tumour patients cannot afford to wait. It was a pleasure speaking with you at Parliament earlier this month.
Clinical research is essential, but so is ensuring patients can access promising treatments now that have already completed major clinical trials.
DCVax-L offers real hope, and families like ours know firsthand how urgently accessible treatment options are needed.
Thank you for your continued advocacy. ๐
Nix ๐ retweeted
Replying to @Siobhain_Mc @LisainNJUSA
$NWBO
The UKโs @MHRAgovuk has the opportunity to approve #DCVax, yet nearly three years after the application, there is still complete silence.
For perspective, more than 460 #GBM trials have taken place over the past 15 years. Only one, #DCVax from $NWBO, has shown positive statistical evidence.
Thatโs a success rate of roughly 0.2%.
With that record, why keep pushing for new #GBM trials as the field moves toward combo therapies with checkpoint inhibitors?
Nix ๐ retweeted
This American had his baby stroller broken by Southwest Airlines. He made a video and it went viral, getting over 3 million views
Southwest called him, he thought they were calling to do the right thing and help. It was the compete opposite
โThe person was speaking on behalf of like the top leaders of Southwest, and she was indignant that I had even made that video in the first place. She said anyone who flies with us should know about our limited liability policy, that we don't cover things like broken strollers and car seats and wheelchairs and stuff.
I said, I did know that. My point is I think it's really unfair, and I think you should really consider looking at it and changing it because it negatively affects people's lives who fly with you and their views of you and their decisions to fly with you in the future.
And, um, she said, we have no interest in changing that policy right now.
I said, is there anyone you could get me in contact with who does make those decisions? that I could just talk to you for like a minute? She said, and I quote, I'm the highest person up you're gonna get.
So the highest person up at Southwest that us normal people can talk to wants you to know that they do not care at all if they break your stuffโฆโฆโ
Southwest has gone so far downhill ever since activist hedge fund Elliott Investment Management bought a large stake in the company. They do not care AT ALL about their customers anymore. No free checked bags, everything has gone up in price, they nickel and dime you for everything and their customer service is terrible
Stop flying Southwest

























